[Therapy-resistant disseminated verrucae in an atopic patient with cellular immunodeficiency--successful topical treatment with imiquimod].
A 42- year-old atopic patient had suffered from disseminated verrucae since he was 14 years old. He had been treated with various, often expensive immunomodulatory agents for a long time without appreciable success. Laboratory tests revealed a striking T-cell defect. Topical treatment with imiquimod (Aldara 5% Cream) led to the regression of all verrucae.
Djawari
Djalil
D
Hautklinik der SLK Kliniken Heilbronn Am Gesundbrunnen, Akademisches Lehrkrankenhaus der Universität Heidelberg. djalil.djawari@klinikum-heilbronn.de
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000634:Aminoquinolines / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D000077271:Imiquimod; D007111:Immunity, Cellular / Q000187:drug effects* / Q000276:immunology*; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D014860:Warts / Q000188:drug therapy* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod